Volume : VII, Issue : VIII, August - 2017

Prevalence of Multidrug Resistant (MDR) tuberculosis in MDR suspect patients.

Shital Dhoble, Virendra Kolhe

Abstract :

 Background:  Prevalence of multidrug–resistant tuberculosis (MDR–TB) is increasing all over the world. India has 2nd highest MDR–TB burden in the world after China. Most important risk factor is poor adherence to treatment. But in recent years chances of infection increases in newly diagnosed patients. We aimed to find prevalence of MDR TB in suspected patients.

Methodology: this retrospective study included 677 suspected patients from March 2016 to April 2017 from registered RNTCP patients. The samples of all suspected cases were processed for detection of rifampicin resistance by Cartridge based Nucleic Acid Amplification Testing (CBNAAT) technique. Data was tabulated and analyzed using spss 16.

Results: Out of total 677 suspected patients, 9 (1.33%), 444 (65.58%), and 224 (33.09%)  were classified into Criteria A, B and C. 430 (63.52%) MDR suspect patients were detected to be having MTB. Out of total MDT TB patients, 39 (9.07%) were rifampicin resistant while remaining 391 (90.93%) were sensitive to rifampicin.

Conclusion: Multidrug resistant TB has been an area of growing concern and poses a threat to control of TB.

Keywords :

Article: Download PDF   DOI : 10.36106/ijar  

Cite This Article:

Shital Dhoble, Virendra Kolhe, Prevalence of Multidrug Resistant (MDR) tuberculosis in MDR suspect patients., INDIAN JOURNAL OF APPLIED RESEARCH : Volume‾7 | Issue‾8 | August‾2017

Number of Downloads : 290

References :